000 | 01911 a2200577 4500 | ||
---|---|---|---|
005 | 20250517104451.0 | ||
264 | 0 | _c20170609 | |
008 | 201706s 0 0 eng d | ||
022 | _a1528-1175 | ||
024 | 7 |
_a10.1097/ALN.0000000000001226 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMcGuinness, Shay P | |
245 | 0 | 0 |
_aA Multicenter, Randomized, Controlled Phase IIb Trial of Avoidance of Hyperoxemia during Cardiopulmonary Bypass. _h[electronic resource] |
260 |
_bAnesthesiology _c09 2016 |
||
300 |
_a465-73 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcute Kidney Injury _xblood |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAustralia _xepidemiology |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aCardiopulmonary Bypass _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperoxia _xblood |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aLength of Stay |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Organ Failure _xblood |
650 | 0 | 4 |
_aNew Zealand _xepidemiology |
650 | 0 | 4 | _aOxidative Stress |
650 | 0 | 4 |
_aPostoperative Complications _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aParke, Rachael L | |
700 | 1 | _aDrummond, Kate | |
700 | 1 | _aWillcox, Tim | |
700 | 1 | _aBailey, Michael | |
700 | 1 | _aKruger, Cornelius | |
700 | 1 | _aBaker, Megan | |
700 | 1 | _aCowdrey, Keri-Anne | |
700 | 1 | _aGilder, Eileen | |
700 | 1 | _aMcCarthy, Lianne | |
700 | 1 | _aPainter, Thomas | |
773 | 0 |
_tAnesthesiology _gvol. 125 _gno. 3 _gp. 465-73 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/ALN.0000000000001226 _zAvailable from publisher's website |
999 |
_c26215984 _d26215984 |